ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1848

Identification of Native and Citrullinated Autoantibodies to Psoriasis Related-antigen PsoP27 in Synovial Fluids of Patients with Psoriatic Arthritis

Marina Slobodkin1, Smadar Gertel1, Ari Polachek2, Victoria Furer3 and Ori Elkayam4, 1Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, 2Tel Aviv Sourasky Medical Center, Petah-Tikva, Israel, 3Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 4Tel Aviv Sourasky Medical Center,, Tel aviv, Israel

Meeting: ACR Convergence 2020

Keywords: Autoantibody(ies), citrullination, Psoriatic arthritis, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Psoriatic arthritis (PsA) is an inflammatory joint disease with no serological biomarkers, hence diagnosis is based on clinical evaluation alone. PsA is closely associated with Psoriasis (PsO), with up to 1/3 of psoriatic patients developing PsA via unknown mechanism.

PsoP27 is an autoantigen found in skin lesions of PsO patients (1) and its levels correlate with psoriasis activity (2). PsoP27 is speculated to be involved in other inflammatory processes, yet it was not investigated in regard to PsA or RA.

The most common autoantigens in RA are citrullinated autoantigens which are formed by PAD  (peptidylarginine deiminase enzymes) and can drive the autoimmune response (3). Although known to be present in other diseases, citrullination is commonly associated with RA.

Our aim was to characterize native and citrullinated PsoP27 antibodies (Ab) in synovial fluids (SF) and sera of PsA and RA as compared to osteoarthritis (OA) patients and healthy controls, respectively.

Methods: SF of PsA (n=35), RA (n=11) and OA (n=13) patients and sera of PsA (n=32), RA (n=32) patients and healthy controls (n=31) were analyzed by ELISA for native and citrullinated PsoP27 Ab.

Results: In SF, both native and citrullinated PsoP27 Ab were significantly higher in PsA and RA compared to OA patients (Table 1). Significant correlation was observed between both forms of PsoP27 Ab in SF and swollen joints count (Native: p=0.029, r=0.39, Cit: p=0.041, r=0.369), psoriasis area and severity index (PASI) score (Native: p=0.011, r=0.56, Cit: p=0.008, r=0.369), and CRP levels (Native: p=0.017, r=0.446, Cit: p=0.03, r=0.408). In contrast, in RA patients there was no correlation between levels of PsoP27 Ab in SF and swollen joint count or CRP levels. No difference in PsoP27 Ab were detected in sera of all groups (Table 2).

Conclusion: We determined for the first time the presence of antibodies to psoriatic-related autoantigen PsoP27, in SF of PsA and RA patients. Furthermore, we showed a positive correlation between levels of PsoP27 Ab and disease activity in PsA, but not in RA. Also, we demonstrated the presence of citrullinated antibodies in PsA, commonly thought to be specific to RA. Our results suggest that PsoP27 Ab in SF may be utilized for diagnosis and disease assessment in PsA.

References:

  1. Iversen OJ, Lysvand H, Jacobsen T, Bergh K, Lie BA. The psoriasis-associated antigen, pso p27, is expressed by tryptase-positive cells in psoriatic lesions. Arch Dermatol Res. 1995;287(5):503-5.
  2. Dalaker M, Jacobsen T, Lysvand H, Iversen OJ. Expression of the psoriasis-associated antigen, Pso p27, is inhibited by cyclosporin A. Acta Derm Venereol. 1999;79(4):281-4.
  3. Gudmann NS, Hansen NU, Jensen AC, Karsdal MA, Siebuhr AS. Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options. Autoimmunity. 2015;48(2):73-9.

Table 1. PsoP27 Ab level (Optical Density, OD) in SF of PsA, RA and OA patients.

PsoP27 Ab level (OD) in sera of patients with psoriatic arthritis (PsA), rheumatoid arthritis (RA), and healthy controls (HC).


Disclosure: M. Slobodkin, None; S. Gertel, None; A. Polachek, None; V. Furer, None; O. Elkayam, None.

To cite this abstract in AMA style:

Slobodkin M, Gertel S, Polachek A, Furer V, Elkayam O. Identification of Native and Citrullinated Autoantibodies to Psoriasis Related-antigen PsoP27 in Synovial Fluids of Patients with Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/identification-of-native-and-citrullinated-autoantibodies-to-psoriasis-related-antigen-psop27-in-synovial-fluids-of-patients-with-psoriatic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-native-and-citrullinated-autoantibodies-to-psoriasis-related-antigen-psop27-in-synovial-fluids-of-patients-with-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology